rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
1995-3-30
|
pubmed:abstractText |
The present study compared the extent and duration of MAO inhibition by the selective and reversible MAO-A inhibitor brofaromine with the selective and irreversible MAO-A inhibitor clorgyline using amine pressor tests and excretion of urinary amine metabolites (MHPG, tryptamine). The pharmacological characterization of clorgyline as an irreversible and brofaromine as a reversible MAO-A inhibitor in clinically effective doses was confirmed in humans.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0300-9564
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
95
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
241-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7865179-Administration, Oral,
pubmed-meshheading:7865179-Adult,
pubmed-meshheading:7865179-Blood Pressure,
pubmed-meshheading:7865179-Clorgyline,
pubmed-meshheading:7865179-Cross-Over Studies,
pubmed-meshheading:7865179-Dose-Response Relationship, Drug,
pubmed-meshheading:7865179-Drug Synergism,
pubmed-meshheading:7865179-Female,
pubmed-meshheading:7865179-Humans,
pubmed-meshheading:7865179-Hypertension,
pubmed-meshheading:7865179-Infusions, Intravenous,
pubmed-meshheading:7865179-Male,
pubmed-meshheading:7865179-Methoxyhydroxyphenylglycol,
pubmed-meshheading:7865179-Monoamine Oxidase,
pubmed-meshheading:7865179-Norepinephrine,
pubmed-meshheading:7865179-Piperidines,
pubmed-meshheading:7865179-Reference Values,
pubmed-meshheading:7865179-Tryptamines,
pubmed-meshheading:7865179-Tyramine
|
pubmed:year |
1994
|
pubmed:articleTitle |
Monoamine oxidase inhibition by the MAO-A inhibitors brofaromine and clorgyline in healthy volunteers.
|
pubmed:affiliation |
Human Pharmacology Institute, Ciba-Geigy GmbH, Tübingen, Federal Republic of Germany.
|
pubmed:publicationType |
Journal Article
|